Living with Crohn’s disease means managing a condition that does not follow predictable rules. Flares arrive without warning, fatigue persists even in remission, and for many patients, the standard treatment pathway controls the disease without fully restoring quality of life.
If you have reached that point and are asking: can medical cannabis help with Crohn’s disease? This article looks at what the evidence actually shows and what exploring this option looks like in the UK.
Key Takeaways
- Crohn’s is a form of inflammatory bowel disease (IBD) causing chronic gut inflammation that can significantly affect daily life
- Medical cannabis has been prescribed fewer than five times on the NHS since it became legal in 2018; private specialist clinics are the only realistic route for most patients
- Research suggests cannabis-based medicines may help with pain, nausea, poor appetite, and sleep in some Crohn’s patients
- Eligibility requires a confirmed diagnosis and at least two prior treatments that have not provided adequate relief
- A free eligibility check is the first step with no commitment required
What is Crohn’s Disease and How Does It Affect Daily Life?
Crohn’s disease is a form of inflammatory bowel disease (IBD) in which the immune system attacks the gut lining, causing chronic inflammation anywhere along the digestive tract.
Unlike irritable bowel syndrome (IBS), which is a functional disorder, Crohn’s causes visible tissue damage and ulceration. The two conditions are biologically distinct, with different diagnostic criteria and different treatment pathways.
For a closer look at how the two differ, explore our resource on medical cannabis for IBS, where the IBS side is covered in more detail.
Symptoms of Crohn’s disease include persistent diarrhoea, abdominal pain, fatigue, unintended weight loss, nausea, and reduced appetite. Research by the University of Nottingham found that over half a million people in the UK are living with IBD, approximately one in every 123 people. ¹ Fatigue is consistently ranked as the greatest impact on quality of life for IBD patients.
How is Crohn’s Disease Typically Treated?
Most people with Crohn’s start with steroids to bring a flare under control, then move on to longer-term medication to keep the disease in remission. These might include immunosuppressants or, for more severe cases, biologics, which are injected or infused medicines that target specific parts of the immune system. Around 70% of people with Crohn’s disease require surgery at some point. ¹
For many patients, this pathway works well enough. For others, the medication either stops working over time, never works well enough, or causes side effects that make continuing difficult. It is this group, people who have genuinely exhausted the standard options, for whom a specialist may consider cannabis-based medicines as a next step.
The Endocannabinoid System and Gut Health
Your body already has a built-in system that helps control pain, inflammation, appetite, and how your gut moves. It is called the endocannabinoid system (ECS). Receptors from this system are found throughout the gut, which is part of why cannabis can affect digestive symptoms at all.
Research has found that people with IBD show lower levels of certain natural compounds in this system in inflamed gut tissue compared with healthy tissue. ³ When cannabis-based medicines interact with these receptors, some patients report improvements in pain, appetite, and gut symptoms. It is not fully understood yet, but the biological connection is there.
Crohn’s Disease and Medical Cannabis Evidence: What the Research Shows
The research on medical cannabis for Crohn’s disease is still developing, but there is more to it than most people expect.
What Research Has Found
- A 2013 randomised controlled trial (RCT) by Naftali et al. found a clinical response in 10 of 11 patients in the cannabis group compared with 4 of 10 in the placebo group, with complete remission in 5 of 11 versus 1 of 10. The primary endpoint was not statistically significant due to the small sample of 21 patients, and the findings should be interpreted accordingly. ⁴
- A 2025 systematic review in the Irish Journal of Medical Science pooled RCT data and found higher clinical remission rates at 8 weeks in cannabis groups versus controls, though quality of life improvement was also seen in placebo groups, highlighting the need for larger trials.⁵
- A 2024 analysis from the UK Medical Cannabis Registry (UKMCR) followed 116 IBD patients over 18 months and found statistically significant improvements in IBD-specific quality of life (SIBDQ), anxiety (GAD-7), sleep quality, and general health-related quality of life (HRQoL). Around 25.86% achieved a minimal clinically important difference in IBD quality of life scores. Adverse events were reported by 17.24% of patients, with none life-threatening.⁶
An Honest Note on the Evidence
The Crohn’s disease medical cannabis evidence consistently points to improvements in symptoms and quality of life rather than changes to the underlying inflammatory process. Asking can medical cannabis help with Crohn’s disease is a reasonable, and the honest answer is: for symptoms, yes in many cases. For the underlying inflammation, the evidence is not yet there.
Markers such as C-reactive protein (CRP) and faecal calprotectin have not significantly changed in most trials. Specialist clinicians use this evidence alongside a patient’s full history to decide whether a CBPM is appropriate.
Who May Be Eligible for Medical Cannabis for Crohn’s in the UK?
A common question is: can medical cannabis help with Crohn’s disease, and if so, would I qualify? Eligibility for medical cannabis for Crohn’s in the UK is assessed individually by a GMC-registered specialist clinician. No GP referral is required. Patients need a confirmed diagnosis, evidence that at least two prior treatments have not provided adequate relief, and no relevant contraindications.
In a Crohn’s context, two prior treatments might mean corticosteroids and an immunosuppressant that caused significant side effects, or a biologic that failed to achieve adequate symptom control.
Consider someone managing Crohn’s disease for several years, initially treated with corticosteroids and later an immunosuppressant that caused significant side effects, who still experiences pain and fatigue affecting their ability to work and sleep. That kind of history is typically what a specialist wants to review.
Exploring Medical Cannabis for Crohn’s Through LeafEase
Medical cannabis has been prescribed five times on the NHS since it became legal in 2018.⁷ For most Crohn’s patients, a private specialist clinic is the only realistic route. At LeafEase, consultations take place by video with a GMC-registered specialist clinician. No GP referral is needed. The specialist reviews your full Crohn’s history before any prescription is considered.
How Your Journey looks at LeafEase
The LeafEase Advantage subscription at £31.99 per month includes follow-up consultations with the same clinician, formulation reviews built around your daily routine, and free home delivery. Medication arrives from a licensed UK pharmacy partner in plain, discreet packaging with no indication of the contents on the outside. LeafEase is registered with the Care Quality Commission (CQC).
If you are living with Crohn’s disease and feel you have reached the limits of your current treatment, checking your eligibility with LeafEase takes a few minutes and gives you a clearer picture of whether a specialist consultation might be the right next step.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always inform your doctor or prescriber about any current medications before starting new treatment. Whether medical cannabis is appropriate for you can only be determined by a GMC-registered specialist after a full clinical assessment. To find out whether you may be eligible, visit leafease.co.uk.
Frequently Asked Questions
Can medical cannabis treat Crohn’s disease?
Research suggests cannabis-based medicines may help manage symptoms such as pain, nausea, poor appetite, and sleep disturbance in some patients. Medical cannabis does not cure Crohn’s disease and current evidence does not show it reduces underlying gut inflammation at a tissue level. Whether it is appropriate for you depends on your individual history and is something a specialist clinician would assess.
Is medical cannabis available on the NHS for Crohn’s disease?
Medical cannabis has been prescribed five times on the NHS since it became legal in 2018. For most Crohn’s patients, access is through private specialist clinics, which carry out a full clinical assessment before prescribing. NHS access remains limited to a small number of licensed products for specific conditions, which do not currently include most IBD presentations.
What treatments do I need to have tried before accessing medical cannabis for Crohn’s?
Generally, patients need to have tried at least two prior treatments without adequate relief. In a Crohn’s context, this typically includes something like corticosteroids and at least one other medication, such as an immunosuppressant or biologic, that either did not control symptoms adequately or caused side effects that made it unsuitable. A specialist will review your full treatment history during the consultation.
What symptoms of Crohn’s might medical cannabis help with?
Research and real-world data from the UK Medical Cannabis Registry suggest cannabis-based medicines may help with pain, nausea, poor appetite, sleep difficulties, and anxiety in some Crohn’s patients. These are the areas where evidence is most consistent. Any treatment plan is assessed and monitored by a specialist, with the formulation adjusted if it is not working as expected.
Does medical cannabis interact with Crohn’s medications?
This is an important question to raise during your specialist consultation. Some cannabinoids can interact with other medications, including immunosuppressants and biologics commonly used in Crohn’s treatment. A LeafEase specialist will review your current medication list as part of the assessment before any prescription is considered.
What is the difference between Crohn’s disease and IBS?
Crohn’s disease is an inflammatory condition where the immune system attacks the gut lining, causing tissue damage, ulceration, and inflammation. IBS is a functional bowel disorder that affects how the gut works rather than causing visible inflammation or tissue damage. The two conditions can produce similar symptoms but have different causes, different diagnostic criteria, and different treatment pathways.
References
[1] Crohn’s & Colitis UK (2022) New research shows over 1 in 123 people in UK living with Crohn’s or Colitis. Available at: https://www.crohnsandcolitis.org.uk/news-stories/news-items/new-research-shows-over-1-in-123-people-in-uk-living-with-crohn-s-or-colitis [Accessed: July 2026].
[2] National Institute for Health and Care Excellence (2019) Crohn’s disease: management. NICE Guideline NG129. Available at: https://www.nice.org.uk/guidance/ng129 [Accessed: July 2026].
[3] Mucosal Immunology (2011) The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Available at: https://www.nature.com/articles/mi201118 [Accessed: July 2026].
[4] Naftali, T. et al. (2013) Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study. Clinical Gastroenterology and Hepatology, 11(10), pp.1276-1280. Available at: https://pubmed.ncbi.nlm.nih.gov/23648372/ [Accessed: July 2026].
[5] Rauf, A. et al. (2025) Cannabis use in Crohn’s disease: a systematic review and meta-analysis of randomised controlled trials. Irish Journal of Medical Science, 194(2), pp.439-446. Available at: https://pubmed.ncbi.nlm.nih.gov/39821383/ [Accessed: July 2026].
[6] Aggarwal, A. et al. (2024) UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology, 18(12), pp.829-838. Available at: https://pubmed.ncbi.nlm.nih.gov/39689344/ [Accessed: July 2026].
[7] The Pharmaceutical Journal (2023) Demystifying medical cannabis: five years on from legalisation. Available at: https://pharmaceutical-journal.com/article/feature/demystifying-medical-cannabis-five-years-on-from-legalisation [Accessed: July 2026].
